Concepedia
Statistics
Publications
6
Citations
320
H-Index
Active since
2013
Affiliations
Janssen (Belgium)(Current)
GlaxoSmithKline (United Kingdom)
Pharmaceutical Product Development (United States)
AstraZeneca (United Kingdom)
Charles River Laboratories (United Kingdom)
Nico van de Merbel is an author at Janssen (Belgium) specializing in mass spectrometric analysis, analytical chemistry, and pharmacy.
Publications per year
2013–2021
The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium
Ronald de Vries, Matthew Barfield, Nico van de Merbel et al. · Bioanalysis · 2013 · 130 citations
Natural Sciences, Biomedical Sciences, Analytical Chemistry +13
In-Depth Study of Homogeneity in DBS Using Two Different Techniques: Results from The EBF DBS-Microsampling Consortium
Zoe Cobb, Ronald de Vries, Neil Spooner et al. · Bioanalysis · 2013 · 64 citations
Life Sciences, Biochemistry, Analytical Chemistry +12
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 1 – Small Molecules by LCMS)
Jan Welink, Eric Fluhler, Nicola Hughes et al. · Bioanalysis · 2015 · 42 citations · Full text
Pharmacy, Pharmaceutical Analysis, Analytical Chemistry +15
2018 White Paper on Recent Issues in Bioanalysis: <i>‘A Global Bioanalytical Community Perspective on Last Decade of Incurred Samples Reanalysis (ISR)’</i> (Part 1 – Small Molecule Regulated Bioanalysis, Small Molecule Biomarkers, Peptides & Oligonucleotide Bioanalysis)
Jan Welink, Yuanxin Xu, Eric Yang et al. · Bioanalysis · 2018 · 39 citations · Full text
Pharmacy, Pharmaceutical Analysis, Analytical Chemistry +16
Change of charge variant composition of trastuzumab upon stressing at physiological conditions
Baubek Spanov, Oladapo Olaleye, Nico Lingg et al. · Journal of Chromatography A · 2021 · 29 citations · Full text
Pharmacy, Pharmaceutics, Pharmacokinetics +17
1–5 of 6